Nicox Sa Stock Analysis
| NICXF Stock | USD 0.44 0.00 0.00% |
Nicox SA is overvalued with Real Value of 0.37 and Hype Value of 0.44. The main objective of Nicox SA pink sheet analysis is to determine its intrinsic value, which is an estimate of what Nicox SA is worth, separate from its market price. There are two main types of Nicox SA's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Nicox SA's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Nicox SA's stock to identify patterns and trends that may indicate its future price movements.
The Nicox SA pink sheet is traded in the USA on PINK Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Nicox SA is usually not traded on Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day. Nicox Pink Sheet trading window is adjusted to America/New York timezone. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Nicox SA's ongoing operational relationships across important fundamental and technical indicators.
Nicox |
Nicox Pink Sheet Analysis Notes
About 17.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 0.99. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Nicox SA has Price/Earnings (P/E) ratio of 146.39. The entity recorded a loss per share of 1.23. The firm had not issued any dividends in recent years. Nicox SA had 1:5 split on the 3rd of December 2015. Nicox S.A. operates as an ophthalmology company in France and internationally. The company was founded in 1996 and is headquartered in Valbonne, France. Nicox Sa operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 32 people.The quote for Nicox SA is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To find out more about Nicox SA contact Michele Garufi at 33 4 97 24 53 00 or learn more at https://www.nicox.com.Nicox SA Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more pink sheets at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Nicox SA's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Nicox SA or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
| Nicox SA generated a negative expected return over the last 90 days | |
| Nicox SA has some characteristics of a very speculative penny stock | |
| The company reported the revenue of 8.58 M. Net Loss for the year was (43.76 M) with profit before overhead, payroll, taxes, and interest of 7.23 M. | |
| Nicox SA has accumulated about 41.97 M in cash with (18.48 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.98, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
Nicox Market Capitalization
The company currently falls under 'Micro-Cap' category with a current market capitalization of 47.99 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Nicox SA's market, we take the total number of its shares issued and multiply it by Nicox SA's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Technical Drivers
In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Nicox SA, as well as the relationship between them. Strictly speaking, you can use this information to find out if the firm will indeed mirror its model of past prices, or the prices will eventually revert. We have analyzed and interpolated zero technical drivers for Nicox SA, which can be compared to its peers in the industry.Nicox SA Price Movement Analysis
The output start index for this execution was nine with a total number of output elements of fifty-two. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Nicox SA middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Nicox SA. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
About Nicox Pink Sheet Analysis
Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how Nicox SA prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Nicox shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as Nicox SA. By using and applying Nicox Pink Sheet analysis, traders can create a robust methodology for identifying Nicox entry and exit points for their positions.
Nicox S.A. operates as an ophthalmology company in France and internationally. The company was founded in 1996 and is headquartered in Valbonne, France. Nicox Sa operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 32 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our pink sheet analysis tools, you can find out how much better you can do when adding Nicox SA to your portfolios without increasing risk or reducing expected return.Did you try this?
Run FinTech Suite Now
FinTech SuiteUse AI to screen and filter profitable investment opportunities |
| All Next | Launch Module |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nicox SA. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in interest. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Complementary Tools for Nicox Pink Sheet analysis
When running Nicox SA's price analysis, check to measure Nicox SA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nicox SA is operating at the current time. Most of Nicox SA's value examination focuses on studying past and present price action to predict the probability of Nicox SA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nicox SA's price. Additionally, you may evaluate how the addition of Nicox SA to your portfolios can decrease your overall portfolio volatility.
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Stocks Directory Find actively traded stocks across global markets | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |